# Belviq (lorcaserin) & cancer signal

> Weight-loss drug withdrawn after a clinical trial cancer signal and related patient claims.

**Canonical URL:** https://drugsmonitor.com/injuries/belviq-cancer-risk
**Last updated:** 2026-06-11

**Related cases:** https://drugsmonitor.com/case/belviq-lorcaserin-lawsuit

Lorcaserin was approved for weight management but withdrawn after a safety trial suggested increased cancer diagnoses.

Civil claims examine warning adequacy and individual diagnosis timing relative to use.

Oncology pathology and prescribing dates are common intake documents.

---

*Educational injury overview. Not medical advice.*